Phytochemistry and Medicinal Value of Harad (Terminalia chebula Retz.) the Ã¢ÂÂKing of Medicinal PlantsÃ¢ÂÂ
Narendra Kumar* and Paul Khurana SM
Amity Institute of Biotechnology, Amity University Haryana, Manesar, Gurgaon-122413, India
- *Corresponding Author:
- Narendra Kumar
Amity Institute of Biotechnology
Amity University Haryana
Manesar, Gurgaon-122413, India
Terminalia chebula, popularly known as Harad, black- or chebulic myrobalan contains hydrolysable tannins. This dominantly contains many phytochemicals viz., casuarinin, chebulanin, chebulagic acid, chebulinic acid corilagin, ellagic acid, gallic acid, neochebulinic acid, punicalagin, 1,2,3,4,6-penta-O-galloyl-β-D-glucose,1,6-di-o-galloyl-D-glucose,3,4,6-tri-o-glloyl-D-glucose, terchebulin. There are many medicinal investigations recording viz., antiulcer, antioxidant, anticarcinogenic, antimutagenic, radio protective, hepatoprotective, cardioprotective, cytoprotective, antidiabetic, renoprotective, antibacterial, antifungal, antiviral, antiprotozoal, anti-inflammatory, antiarthritic, antispasmodic, wound healing and anticonceptive, molluscidal, anthelmintic, anaphylactic, hypolipidemic, hypocholesterolemic. Also having chemopreventive potential and adaptogenic activities. This has purgative property, immunomodulatory, analgesic, antiallergic, neuroprotective, acetylcholine inhibition activity and have gastrointestinal motility improving activity. This is beneficial in bronchial asthma and also useful as dye for fabrics.
Terminalia chebula, Phytoconstituents, Antiulcer, Anticarcinogenic, Antimutagenic, Anthelmintic, Cardioprotective, Cytoprotective
Terminalia chebula Retz. (Harad) belonging to Family-Combretaceae grows abundantly especially in Northern India and in the forests of Assam, West Bengal, Bihar and also Konkan. This have applications in Ayurveda, Homoeopathic and Unani system of medicines. The plant T. chebula is a gentle purgative, astringent and is used in prescriptions for treating constipation, flatulence, dysentery, diarrhoea, cyst, digestive disorders, vomiting, enlarged liver and spleen, cough, bronchial asthma since antiquity and for metabolic harmony. Its bark is diuretic. The fruits of the tree give various health benefits. The powder of mature fruits has also been in use in intermittent fevers, chronic fevers, anaemia and polyuria  and against various human ailments [2,3] including diabetes .
T. chebula (Harad) is widely used in the traditional medicine of India and Iran to treat diseases that include constipation, dementia and diabetes . It is one of the three constituents of triphala used in India as common herbal medicine.
This contains many phytoconstituents that is useful in various human related diseases. The main purpose of this essay is to find information conducted on different pharmacological and phytochemical investigations done on different parts of the T. chebula plant. It may be useful in removing human health problems.
English-Chebulic Myrobalan, Black Myrobalan; Hindi; Harra, Harad; Ayurvedic-Haritaki, Kaayasthaa, Pathyaa, Shreyasi, Shivaa. (Jivanti Puutanaa, Vijayaa, Abhayaa, Rohini, Chetaki, Amritaa; Unani-Harad, Halelaa siyaah, Halelaa zard, Halelaa Kaabuli (varieties); Siddha/Tamil- Kadukkai.
Ecology and distribution
T. chebula shows its distribution as mixed deciduous tree in forests of teak and uses light strongly. This can withstand some shade and can benefit in protection from sun effect (Figure 1). This being drought and frost tolerant can withstand fire so can recover well in burning. It shows poor regeneration. This is mainly because the fruits are taken away by farmers of local area and through animal’s predation. This being medium to large deciduous tree attains 98 ft (30 mt) tallness and having a trunk up to 3 ft 3 in (1 m) in range. The leaves being subopposite to alternate in sequence. They are oval 4.5-10 cm (1.8-3.9 in). Petioles are in the range of 0.39-1.18 in (1-3 cm) and 2.8-3.1 in (7-8 cm) long. It bears cordate base with acute tip. The flowers circulates an unpleasant odour. They are monoecious and white-yellow in colour (Figure 1). Broadness of fruit is 0.47-0.98 in (1.2-2.5 cm) and length 0.79-1.77 in (2-4.5 cm). Longitudinal ridges on fruits are five and blackish in dry form. Fresh fruits ellipsoidal, ovoid, smooth, orange-brown-yellow and stony drupes (Figure 2).
T. chebula phytoconstituents
|Body of the Plant||Pyrogallol, phloroglucimol, ferulic, vanillic, p-coumaric, caffeic acids||Khare |
|Kernels portion of the seed||Oleic, linoleic, stearic, palmitic, behenic, linoleic, oleic and arachidic acids||Khare |
|Fruits||Mannitol, ethyl gallate, gallic, tannic, ascorbic, ellagic, chebulic corilagin||Grover and Bala |
|Tannins, anthraquinones, chebulinic acid, chebulagic acid, chebulic acid, ellagic acid and gallic acid. The other minor compounds include polyphenolic compounds, triterpene glycosides, terchebulin, punicalagin, terflavin-A, flavonoids like rutin and quercitin, terpenene glycosides, arjungenin and arjunglucoside-I and a small quantity of phosphoric, succinic, syringic and quinic acids||Inamdar et al., Khanna et al. |
|Oleic, palmitic and linoleic acid||Zhang et al. |
|Punicalagin, polyphenols corilagin, galloyl glucose, terflavin A, maslinic acid||Williumson, |
|Hydrolysable tannins (Gallic acid, chebulagic acid, punicalagin, chebulanin, corilagin, neochebulinic acid, ellagic acid, chebulinic acid, 1,2,3,4,6-penta-O-galloyl-β-D-glucose, 1,6-di-o-galloyl-D-glucose, casuarinin, 3,4,6-tri-o-glloyl-D-glucose, terchebulin)||Juang et al. |
|Gallic acid, chebulic acid, punicalagin, chebulanin, corilagin, neochebulinic acid, ellagic acid, chebulagic acid, chebulinic acid, 1,2,3,4,6-penta-Ogalloyl-β-D-glucose, 1,6-di-O-galloyl-D-glucose, casuarinin, 3,4,6-tri-O-galloyl-D-glucose, terchebulin and Hydrolysable tannins||Lee et al., |
|Bioflavonoids and Polyphenols||Newairy and Abdou |
|Betasitosterol, fructose, amino acids, resin and purgative principle of anthraquinone||Thakur et al., ; Tubtimdee and Shotipruk |
|Coumarin conjugated with gallic acids called chebulin triterpenoids, glycosides, flavonol||Yoganarasimhan ; Rangsriwong et al., ; Muhammad et al., |
|Betasitosterol, purgative principle of anthraquinone, fructose, amino acids, succinic acid, resin||Tubtimdee and Shotipruk ; Thakur et al., |
|Alkaloids, flavonoids, carbohydrates, glycosides, tannins, terpenoids, Phenols and absence of fixed oils and steroids||Raju et al., |
|Flavonol, glycosides, triterpenoids, coumarin conjugated with gallic acids called chebulin||Rangsriwong et al., |
|Hydrolysable tannins, gallic acid, chebulic acid, chebulic ellagitannins, and gallate esters||Pfundstein et al., |
|Glycosides-Triterpenoid such as chebulosides I and II, arjunin, 2α-hydroxyursolic acid, 2α-hydroxymicromiric acid and arjunglucoside||Mammen et al., |
|Triterpenoid contents maximum in methanolic extract while water extract contained max. total tannin and phenolics||Chang and Lin |
|Tannins, saponins, flavonoids and alkaloids||Saha and Verma |
|Leaf||Polyphenols such as sterflavins B, C and D, punicalagin, punicalin||Bruneton ; Juang et al., ; Han et al., |
|Increasing order of phenolics, tannins, flavonoids and flavonol contents in various solvent extracts were for acetone > ethyl acetate > methanol > water > chloroform > petroleum ether||Kathirvel and Sujatha |
|Phenolics, triterpenoids, and flavonoids, gallic acid||Eshwarappa et al., ; Shankara et al., |
Table 1: Phytochemical constituents on different portions of Harad
The herbal products are measured to be the symbols of safety in comparison to the synthetic products that are regarded to be hazardous to human life and environment. This plant has immense medicinal potentials as follows-
Antiulcer activity in T. chebula Methanolic Extract (METC) was recorded through work of Raju et al.  in ethanol induced ulcer models through pylorus ligation in Wistar rats. They found that METC produced reduction of the gastric lesions induced through Pylorus ligation @250, 500 mg/kg significantly. During application of hydrochloric extract @200 and 500 mg/kg it was able to produce significant reduction in total affected area, lesion index and lesion per centage when compared with control (P <0.05 and P < 0.01) through stress induced ulcer models in the aspirin, ethanol and cold restraint. But at 200 and 500 mg/kg it produced antisecretory actions [33,34].
The oxidative stresses may pose serious problem the reason is that diseases persists through a dis-balance in detoxifying pro-oxidants. So a right alternative may be the use of natural antioxidants which has been in use as traditional medicines. Now interest increasing in use medicinal plants having antioxidant activity. The work on antioxidant nature of T. chebula is compiled in Table 2.
|Source||Observed antioxidant potential||Reference|
|Leaf||Methanol Extract (METC), Water Extract (WETC), 95% Ethanol Extract (EETC), fermented product of dried powder at 15°C and fermented product of water extract at 25°C exhibited antioxidant activity based on the pyrogallol-luminol assay||Chang and Lin |
|Fruit||Highest antioxidant function was found in the ethanolic extract||Kushwaha et al., |
|Checked nitric oxide release and free radical induced haemolysis through lipopolysaccharide stimulated murine macrophages while using polyherbal formulation (NR-A2/Aller-7)||Mahesh et al., |
|Acetone extract showed stronger antioxidant activity||Chen et al., |
|Water extract appeared to have good antioxidant activities in cupric sulfate-Phen-Vc-H2O2 and luminol-H2O2 assays. Pyrogallol-luminol assay showed the 95% ethanol extract to have good antioxidant activity||Chang and Lin |
|Showed various magnitudes of potency as antioxidant activity||Hazra et al., |
|Lipid peroxidation inhibition in microsomes of rat liver in different doses through radiation||Lee et al., |
|Methanolic extract inhibited formation of lipid peroxide and also scavenge superoxide hydroxyl and radicals in vitro||Lee et al., |
|The aqueous T. chebula extract showed potent antioxidant activity when microsomes exposed @100 Gy to 600 Gy. Considerable reduction in the extent of lipid peroxidation was observed||Naik et al., |
|Significant antioxidant nature in methanolic extract when compared to ascorbic acid through dose dependent mode. In nitric oxide scavenging assay, the IC50 value 51.3 µg/ml while the IC50 value of ascorbic acid was 77.4 µg/ml. showed strong reducing power and total antioxidant activity of the extract also increased at different doses||Sarwar et al., |
|Depicted better antioxidant activity (IC50 0.032 mg/ml) to reduce 2, 2-Diphenyl-1-Picrylhydrazyl (DPPH)||Mathen et al., |
|Possessed powerful reducing ability, nitric oxide scavenging activity which also scavenges hydrogen peroxide induced radicals.||Saha and Verma., |
|Leaf extract||Showed inhibition of xanthine/xanthine oxidase activity and also as DPPH radicals excellent scavenger||Naik et al., |
|Antioxidant potential of leaves, evaluated in vitro DPPH-radical scavenging activity and reported it to be safe source of functional food as natural antioxidant resource||Kathirvel and Sujatha |
Table 2: Antioxidant potential of Terminalia chebula
Plants have been an important source for discovery of anticancer compounds. With the current decline in the number of new molecular entities from the pharmaceutical industry, novel anticancer agents are being sought from traditional medicines therefore the anticancer efficacy has been evaluated using various cell lines and information generated is compiled below (Table 3).
|Fruit||Inhibited growth of cancer cells||Saleem et al., |
|Fruit||Induced death of cell, inhibited proliferation of cell in ethanolic extract of many cell lines being malignant in human Prostate Cancer Cell (PC-3), Human Osteosarcoma Cell Line (HOS-1), Mouse (S115) Breast Cancer Cell Line including Human (MCF-7), in Non-tumorigenic Immortalized Human Prostate Cell Line (PNT1A)||Reddy et al., |
|Bark and fruit powder||Acetone extract showed promising anticarcinogenic activity||Reddy et al., |
|Inducer of apoptosis in lung cancer cell lines potently||Saleem et al., |
|Fruits||Increase of lifespan of the mice through restoration of haematological parameters @200 mg/kg when given orally and found to be cytotoxic in the in vitro showing its significant anticancer potential.||Ahuja et al., |
|Fruit powder @500 µg/ml of each fraction was used against cells of the A549 lung cancer cell line using the MTT assay, at 48 h Fraction 3 exhibited the lowest rate of growth inhibition while fraction 4 exhibited the highest rate||Wang et al., |
|Leaf gall extract||Ethanolic leaf gall extract was evaluated against buffalo rat liver 3A, MCF-7 (Human mammary gland adenocarcinoma) and A-549 (Human lung cancer) cell lines by MTT assay. The extract was potent and effective in inducing cytotoxic effects in all the cell lines as IC50 value of 305.18 ± 1.7 μg/ml, 643.13 ± 4.2 μg/ml and 208.16 ± 3.7 μ/ml, respectively. The extract was more effective against A549 cell lines than the others.||Shankara et al., |
Table 3: Observed anticarcinogenic activity
Antimutagenic, radio protective and chemopreventive potential
Grover and Bala  found antimutagenic activity in hydrolyzable tannins and aqueous extract of T. chebula against Salmonella typhimurium. Gandhi and Nayar  studied mice liver and reported peroxidation reduction in membrane lipids. There was a decrease in radiation damage to DNA through application of T. chebula aqueous extract. This protected from undergoing induced damage from gamma radiation to DNA of human lymphocytes when exposed in vitro. The tannin fraction of T. chebula extract showed efficacy as highly significant against 2AF-S9-dependent mutagen. However, chebula tannins though partly effective against NPD mutagen may not be effective against mutagen 4NQNO . Prasad et al.  reported chemopreventive effect of T. chebula on nickel chloride-induced toxicity, proliferation response in cells of male wistar rats and renal oxidative stress.
To obtain experimental evidence and assess the antimutagenic activity, Chromosomal Aberration (CA) and Micronucleus (MN) formation in C57BL hybrid mice were examined. In MN formation test, single application of T. chebula methanolic fruit extract at different doses of 50, 100 and 150 mg/kg dry weight 24 h prior to administration of Cyclophosphamide (CP) at @50 mg/kg significantly reduced the frequency of MNCPE and at the same time significantly increased PCE/NCE ratio as compared to CP alone. Concerning CA test, fruit extract at all different doses significantly reduced the % CA and at the same time increased the % degree of protection in dose dependent manner in bone marrow cells of mice as compared to CP alone treated group. However T. chebula fruit extract alone did not show any chromosomal aberration and/or micronucleus formation. These results clearly, indicate the antimutagenic activity of the TC fruit extract .
In a radiation dose 270 Gy the lipid peroxidation was studied in varying concentration (5 to 35 μg/ml) of the extract which showed protection efficacy in varying concentrations. At 15 μg/ml of the extract the peroxidation is inhibited by 50% (IC50 value) . The traditional ayurvedic decoction of T. chebula harbours its efficacy as a low cost, safe chemopreventive agent if given according to the ayurvedic specifications at the intestinal level .
This is the liver which may control various physiological actions of the entire body. If any injury happens it will damage liver. Since Harad have radical scavenging activity it may be useful in prevention of liver damage. It has been recorded that 95% ethanolic fruit extract of T. chebula showed hepatoprotective activity against toxicity induced antituberculosis drug which in turn might be due to prominent antioxidative and membrane stabilizing activities .
The ethanol extract prevented hepatotoxicity through T. chebula when rifampicin/isoniazid and in combination of pyrazinamide was applied in sub-chronic model (12 weeks) . The herbal formulation (HP-1) of T. chebula was found exhibiting hepatoprotective activity in rat hepatocytes against induced toxicity of carbon tetrachloride . The Chebulic Acid (CA) and neochebulic acid in a combination of 2:1 extracted from ethanolic extracts of fruit of T. chebula exhibited strong hepatoprotective activity .
Fruit of T. chebula is an ayurvedic remedy and if given orally it can work as detoxifying agent and a generic intestinal . Which was studied on 2-Acetylaminofluorene (2-AAF) activated hepatocellular carcinoma of mice. There was liver aberration and Multidrug Resistance-1 (MDR1), generation of reactive oxygen species (ROS), Cyclooxygenase-2 (COX-2) expression through phosphorylation of Akt-MAPKs and nuclear translocation of NF-κ at B25 mg.kg-1 b.w. 2-AAF. The pre administration of 50 mg.kg−1 TCE along with 25 mg.kg−1 2-AAF inhibited the expression of MDR1 by preventing ROS generation and COX-2 expression through Akt and MAPK signalling pathway. This is useful in preventing the possible neoplastic transformation leading to hepatocarcinoma .
In iron dextran injection model 70% methanol and 95% ethanol extract of T. chebula showed hepatoprotective effects in animal models . I t was observed that t-BHP injection notably increased in the liver tissue in the presence of malondialdehyde, total reactive oxygen species and nitric oxide. It showed again a drop in the antioxidant activities including total antioxidant capacity, glutathione peroxidase, superoxide dismutase, total glutathione contents and catalase. TCW pretreatment ameliorated remarkably these alterations and also relevant in gene expressions .
Forty four rats of age group 90-120 days having 150-200 g were chosen and after 14 days of settlement they were divided equally in two experimental and control groups. The control set was again divided into paracetamol treated control (PC, n=11) and base line control (BC, n=11). The experimental group were again kept in 2 groups as pretreated T. chebula and paracetamol treated (TCP-PCT, n=11). They were given basal diet up to 21 consecutive days. It was concluded from this study that T. chebula has hepatoprotective effect against paracetamol induced rat liver damage .
To assess the effect of ethanolic fruit extract of T. chebula induced Hepatotoxicity in rats, they were divided into six different groups each having six rats. Group 1 served as the control, Group 2 received 40% ethanol (2 ml/100 g, oral), in sterile water, group 3, 4 and 5 served as extract treatment groups and orally received 50, 100 & 200 mg/kg, orally, ethanolic fruit Extract of T. chebula (TCE) and group 6 served as the standard control and received Silymarin 25 mg/kg. All the treatment protocols followed 21 days after which rats were sacrificed and blood samples taken for biochemical studies. The ethanol treated group rats (G2) showed variable increase in serum Amino Transferase (AST), Alanine Amino Transferase (ALT) and Alkaline Phosphatase (ALP) levels. Moreover, total protein and total bilirubin levels were significantly increased in treatment groups. The effect of extract was compared with a standard drug, silymarin. It was concluded that the ethanolic fruit extract of T. chebula protects against ethanol-induced oxidative liver injury in rats .
In a study it was noticed that extract of T. chebula can retain enzymes role as a diagnostic marker in rats myocardial damage which is induced through isoproterenol. This ameliorated isoproterenol activity during lipid peroxide formation  but its pericarp have cardioprotective activity .
The two chemicals such as Gallic acid (GA) and CA extracted from T. chebula fruit can block lymphocyte-mediated cytotoxic cytotoxicity . The ethanolic extract of fruits have cytoprotective effect on the HEK-N/F cells. While in UV-induced oxidative damage this have significant cytoprotective activity. This is because of the T. chebula extract inhibitory effect in age dependent telomere length shortening which might be due to terminal restriction fragments of DNA Southern Blots obtained in sub culture passages . This formed duodenal ulcers and showed cytoprotective effect in vitro in the gastric mucosa . The T. chebula fruit extract produced cytoprotective effect on oxidative stress and it was inhibitory to cellular aging .
Renoprotective and antidiabetic
In an animal study T. chebula, T. belerica, Emblica officinalis methanolic extract individually and their combination ‘Triphala’ were found to reduce the blood sugar level significantly within 4 h comparable to standard control . The ethanolic extract of T. chebula fruit has potential hypoglycemic action in Streptozotocin induced diabetic rats. T. chebula showed more hypoglycemic effect than standard therapeutic drug, glibenclamide .
In other long term/short term investigation revealed that chloroform extract of T. chebula showed dose dependent reduction of blood glucose in diabetic rats in comparison to standard drug, glibenclamide. It also revealed action of T. chebula in reduction blood glucose which got mediated through enhanced secretion of insulin through β-cells of Langerhans. There was significant reno-protective activity in T. chebula treated rats . The T. chebula seeds and fruit showed reduction in blood glucose which was dose dependent in streptozotocin induced diabetic rats both in short and long term studies. It also showed an effective renoprotective potential [67,68].
Antibacterial. Time to time researchers have investigated antibacterial activity of T. chebula as summarised below (Table 4).
|Fruit||Ethyl ester and GA obtained from ethanolic extract showed antibacterial activity against methicillin-resistant Staphylococcus aureus||Sato et al., |
|Inhibited the urease activity of Helicobacter pylori effectively||Malckzadeh et al., |
|Methanolic extract of leaf proved potent equally effective antibiotics such as kanamycin, gentamycin, ciprofloxacin, ofloxacin and cephalexin in comparison to the aqueous extract.||Ghosh et al., |
|Inhibited the growth of salivary bacteria Streptococcus mutants through aqueous extract||Aneja and Joshi |
|Strong antibacterial against many bacteria which is human pathogenic for both Gram-positive and Gram-negative||Khan et al., [73,74]|
|Strongly useful in the management of citrus canker disease through inhibitory action on strain X-100 of the bacterium Xanthomonas campestris pv. citri||Kannan et al., |
|Strong inhibitory activity on Salmonella typhi, Klebsiella and intestinal bacteria||Rani and Khullar ; Agrawal et al., |
|T. chebula fruit extract highly active against Bacillus subtilis Staphylococcus aureus Salmonella typhi, Staphylococcus epidermidis, and Pseudomonas aeruginosa||Kannan et al., |
|Strong antibacterial activity against multidrug-resistant uropathogenic Escherichia coli in ethanolic fruit extract||Bag et al. [78,79]|
|Ripe seeds||Exhibited strong antibacterial potential against S. aureus||Bonjar |
|Leaves||Acetone extract showed higher inhibitionsfor B. subtilis, E. faecalis, K. pneumoniae, S. aureus and C. diphtheria for. Particularly B. subtilis, E. faecalis, K. pneumoniae showed higher activity than the standard, Streptomycin while S. boydii responded to acetone extract S. typhi however showed higher antibacterial activity for water extract.||Kathirvel and Sujatha |
Table 4: Antibacterial nature of Terminalia chebula
Antifungal activity of T. chebula has also been found as compiled below (Table 5).
|Fruit||Exhibited antifungal activity against Candida albicans and dermatophytes Microsporum gypsum,Floccosum,Epidermophytonand Trichophyton rubrum in aqueous extract||Dutta et al.,  Barazani et al., |
|Strongly antidermatophytic on (Trichophyton spp.) and on three yeasts (Candida spp.)||Mehmood et al., |
|Strongly anticandidal against clotrimazole resistant Candida albicans in methanolic extract||Bonjar |
|Seed extract||Antifungal activity against Trichophyton glabrata in aqueous seed extract||Barazani et al., |
Table 5: Potential of Terminalia chebula against fungi
Antiviral activity has also been investigated for T. chebula as compiled in Table 6.
|Fruit||Showed strong inhibitory effects on human immunodeficiency virus-1 reverse transcriptase in acetone extract of T. chebula fruits||Mekkaway et al., |
|Strong therapeutic potential in fighting herpes simplex virus both in vitro and in vivo tests||Kurowa et al., |
|Strongly effective in inhibiting the replication of human cytomegalovirus (CMV) in vitro||Yukawa et al., |
|Strongly effective in protecting epithelial cells against influenza A virus||Badmaev and Nowakowski |
|Strong inhibition against the 3′-processing of HIV-1 integrase of the compounds||Ahn et al., ; Jeong et al., |
|Strongly effective for control of AIDS and sexually transmitted diseases||Vermani and Garg |
|Significant inhibitory activity with IC50≤5 µg/ml on human immunodeficiency virus-1 reverse transcriptase in methanolic and aqueous extracts||Gambari and Lampronti ; Ahn et al., ;|
|Tannins strongly effective against potato virus X||Ma et al., |
|Useful in treatment of pandemic swine influenza A infection||Ma et al., |
|Herpes Simplex Virus-1 (HSV-1) causes lifelong latent infection of sensory neurons. Two hydrolyzable tannins, chebulagic acid and punicalagin, isolated from the dried fruits of T. chebula inhibited HSV-1 entry at non-cytotoxic doses in A549 human lung cells by preventing binding, penetration, and cell-to-cell spread, as well as secondary infection||Lin et al., |
Table 6: Antiviral potential of Terminalia chebula
A study was done in rats caecal amoebiasis which showed curative rate of 89% at 500 mg/kg body weight through inhibition of enzyme activities such as RNase, DNase, aldolase, α-amylase, acid phosphatase, protease and alkaline phosphatase in axenically cultured amoebae of varying degree [94,95]. In another study of amoebic liver abscess in golden hamsters and in immunomodulation studies TC showed maximum cure rate against hepatic amoebiasis up to 73% in 800 mg/kg body weight. The humoral immunity got enhanced in immunomodulation studies while T-cell counts remained unaffected while cell-mediated immune response got stimulated . The four botanicals (Boerhavia diffusa, Berberis aristata, Tinospora cordifolia, and Zingiber officinale) along with TC showed maximum cure up to 73% in amoebic liver abscess  but 89% in caecal amoebiasis in rats producing strong inhibitory activity on Entamoeba histolytica . The anti plasmodial activity against Plasmodium falciparum was found to be present in acetone extract of T. chebula seeds .
For the control of alzheimer’s disease acetylcholinesterase inhibitors are useful. The phytochemical 1,2,3,4,6-penta-O-galloyl-β-D-glucose isolated from TC was compared with tacrine which revealed strong acetylcholinesterase and butyrylcholinesterase inhibitory effects . The T. chebula aqueous extract showed highest efficacy to inhibit acetylcholinesterase when tested in comparison with other herbs viz. Emblica officinalis, Terminalia bellirica, Emblica officinalis and Triphala .
Antiarthritic and anti-inflammatory
The T. chebula dried fruit extract inhibited nitric oxide synthesis and showed antiinflammatory activity when used in aqueous form . Chebulagic Acid (CA) obtained T. chebula immature seeds checked development of collagen induced arthritis in mice . The polyherbal formulation (Aller-7) T. chebula showed a dose dependent antiinflammatory effect on Freund's adjuvant induced arthritis in rats .
Nair et al.  reported anti-arthritic effect in T. chebula hydroalcoholic extract (TCHE) through experimental models to compare the effect of treatment on macrophage-derived pro-inflammatory cytokine expression and extent of disease activity. This resulted a potent inhibition of joint swelling when caparisoned with the control in both CFA and formaldehyde produced arthritis. TCHE use reduced serum TNF-α level and synovial expression of TNF-R1, IL-6 and IL-1β. This also resulted antiarthritic activity in TCHE which showed it was at least in part due to its modulatory action on pro-inflammatory cytokine expression in the synovium .
Lipoxygenase (LOX) inhibitors are the promising therapeutic target for treating a wide spectrum of inflammation diseases such as cancer, asthma, lymphoma, leukaemia, and autoimmune disorders. The photochemical constituents, anti-LOX potential of T. chebula leaf galls was evaluated to find out development of medicine. Extracts of T. chebula galls were tested for anti-LOX activity using linoleic acid as substrate and lipoxidase as an enzyme and also the total content of polyphenols with phytochemical analysis of the extract were determined. The higher LOX inhibitory activity was positively correlated to the high content of total polyphenols/flavonoids. This confirms the folklore use of T. chebula leaf gall extracts as a natural anti-inflammatory agent .
Adaptogenic and antianaphylactic
The adaptogenic potential of fruit of T. chebula has been studied along with 6 herbs when administered in animals it was able to relieve in different stresses in different ways . But when administered for anaphylactic shock levels of serum histamine got reduced showing its strong antianaphylactic activity . The aqueous fraction of T. chebula showed inhibition of 48/80-induced anaphylaxis both locally as well as at systemic level. The effect is pronounced in pretreatment when compared with induction of anaphylactogen. The serum histamine release levels from rat peritoneal mast cells were reduced in a dose dependent manner .
Hypolipidemic and hypocholesterolemic
A study revealed that T. chebula extract are effective in atherosclerosis when inducted experimentally and hypolipidemicrole . It also have power of hypocholesterolemic activity on cholesterol produced hypercholesterolemia in rabbits .
Gastrointestinal motility improving and anti-ulcerogenic
The gastric emptying time may be increased while using the fruit of T. chebula but traditionally it has laxative power . This can protect gastro intestinal mucosa. It prevents Brunner's gland secretions which may be useful in duodenal ulcer formation protection .
A study revealed that T. chebula have antispasmodic activity and useful in reduction of blood pressure as well as intestinal spasms. It is also beneficial in intestinal disorders and spastic colon .
A study reported that aqueous T. chebula extract found inhibitory effect on sucrose inducted accumulation of Streptococcus mutans in the saliva samples up to 3 h after rinsing. It also inhibited upto 90 min even after post rinsing . Another study revealed that mouth rinsing through 10% solution inhibited salivary bacterial count [72,110].
The alcoholic extract of T. chebula leaves showed in rat much faster healing in dermal wounds. This is mainly due to decreased period for epithelialization and improved rates of contraction . The studies recorded increase of DNA, collagen, total protein contents in the granulation tissues of treated wounds. The hexosamine and uronic acid levels were got increased up to day 8 on post-wounding. It is helpful in healing process promotion . The healing activity in ethanol extract of T. chebula was reported through indomethacin induced stomach ulceration . The T. chebula hydroalcoholic extract of fruit exhibited 82% reduction in the wound area due to a faster epithelialization when compared to controls in alloxan induced diabetic rats .
The tannins immature fruits T. chebula inhibited Klebsiella pneumonia and Staphylococcus aureus in vitro. This because of having powerful antibacterial and angiogenic activity of the extract accelerated cutaneous wound healing in rats . An ointment at two concentrations (5% and 10% w/w ointment of bark extract) produced a very good result in incision and excision models in albino rats when compared to controls in wound healing action of ethanolic fruits extract of T. chebula .
The aqueous and organic extracts (Solvent-free) of T. chebula were evaluated on keratinocytes and fibroblast (L929) cells. This decreased accumulation of ammonia in the media so reducing toxic effect on cells. The DPPH assay resulted the free radical scavenging ability of the extracts. This got increased with the increase in concentration of each extract. The ECM secretion and cytoskeletal structure of the cells treated with extracts showed higher cellular activity when compared to control .
A study revealed that rats receiving T. chebula treatment noticed reduction in total protein cholesterol, triglycerides. This significantly elevated high density lipoprotein cholesterol showing hypolipidemic activity significantly . In an experimental study including rabbits T. chebula showed significantly lower cholesterolaemia. No cholesterol excretion was found hence the action may be mediated through enzymic degradation of cholesterol either in the liver or elsewhere .
The T. chebula fruit powder has potent molluscicidal activity on Lymnaea acuminata which is a vector snail. This activity is mainly due to tannic acid .
T. chebula fruit extracts were screened to evaluate anthelmintic activity in adult earthworm Pheritima posthuma. The alcoholic and aqueous extract of the fruits showed significant anthelmintic activity. It was higher in alcoholic extract than the aqueous extract and even the standard drug of albendazole .
The ovicidal and larvicidal activities were studied in Haemonchus contortus. The three extracts acetate, acetone and methanol were taken from dried leaves and seeds. This was based on egg hatching and larval development assays at 50, 25, 12.5, 6.25 and 3.13 mg/ml. The leaves and seed extracts 50 mg/ml concentration showed complete [email protected] .
The oil fraction in T. chebula seeds have Purgative activity .
T. chebula have potential to increase humoral antibody titer and useful in delayed type of hypersensitivity . The dried ripe fruits have immunomodulatory activity. The aqueous extract @100 mg/kg/p.o. can increase level of liver mitochondrial enzymes CAT and SO as well as GSH. This can decrease in the level of LPO in the liver when compared to the vehicle cyclophosphamide treated groups/Sheep Red Blood Cells (SRBC) .
The analgesic activity in T. chebula methanolic extract fruits was evaluated using acetic acid-induced writhing test in mice. The extract, @500 mg/kg, showed a maximum of 44.17% inhibition (P < 0.05) of writhing reaction compared to the reference drug diclofenac-sodium (66.96%). The extract also showed moderate cytotoxic activity in brine shrimp lethality bioassay and the LC50 value was found to be 97.36 μg/ml .
This have got antiallergic activity. This was confirmed when polyherbal formulation of seven medicinal plants Aller-7 was prepared along with this and used in guinea pig .
This have neuroprotective activity against H2O2-induced toxicity toward PC12 cells methanol and water extracts. This have bio-potential for the treatment of H2O2-induced neurodegenerative disease at 0.5-5.0 μg/ml .
Another study with T. chebula extract: Showed (1) increase in the survival of cells subjected to OGD-R by 68% and H2O2 by 91.4%; (2) Scavenges the DPPH free radical by 94% and decreases malondialdehyde levels from 237.0 ± 15.2% to 93.7 ± 2.2%; (3) Reduces NO production and death rate of microglia cells stimulated by lipopolysaccharide; (4) Decreases the cerebral infarct volume and extent of hemisphere swelling. This suggested that T. chebula fruit has a very high potential as a natural herbal medicine, to protect the cells from ischemic damage. This is through the inhibition of oxidative and inflammatory processes .
Effect of T. chebula on bronchial asthma
An ayurvedic clinical study reported evaluating two Ayurvedic formulations on bronchial asthma (Tamak shvasa) viz. Shvasahara Leha and Vasaharitaki Avaleha. The results of the study indicate that the Vasa Haritaki Avaleha containing T. chebula provided higher relief than Shvasahara Leha in Tamaka Shvasa .
The ethanol extract of T. chebula exhibited antinociceptive effect claimed to be due to triterpenoids present and may be partially acting through the cholecystokinin receptor pathways .
TC is useful in development of eco-friendly shades on woolen yarn for different hues and tones. In a study the effect of dye concentration on color strength (K/S) of woolen yarn dyed with T. chebula was assessed. This resulted that increasing concentration of dye can decrease lightness values of woolen yarn samples [126,127].
In simple constipations small scale trials have been conducted. This can increase the stools and evacuate the bowel completely  (Singh and Sinha, 1978). Besides some Ayurvedic drugs, along with T. chebula have their effects on mental physical disability, mental stress, constipation, and allergic rhinitis [128,72]. For development of gingivitis and periodontitis Dental Plaque Bacteria (DPB) are associated. The growth of oral bacteria got suppressed through Ethanol Extract of T. chebula (EETC). This reduced the induction of proteases, inflammatory cytokines but abolishing the expression of PGE2 and COX-2. This inhibited the matrix damage so contributing in prevention of bone resorption .
T. chebula has no cellular toxicity on sheep erythrocytes as well as acute oral toxic effects on rats [130,131]. The hydroalcoholic extract of fruits of T. chebula have cytochrome P450 inhibition activity in rats . This had no genotoxic effect . The fruit extract of T. chebula can reduce the induced genotoxicity associated with lead and aluminium [134,135]. The cytotoxicity studies 80 μg/ml on 3T3 cell line revealed only negligible inhibition . T. chebula fruits having hydrolysable tannins showed antimutagenic activity on mutagens like 4-nitro-O-phenylene diamine and sodium azide. These findings revealed that it is safe for used.
Drugs available in market
Haritaki (T. chebula) a mild laxative capsule (90 capsules) have been marketed by Wilson Drugs Jalandhar, Punjab which is effective in use for Constipation, loss of appetite and flatulence.
Conclusions and Recommendations
T. chebula have a wide spectrum of pharmacological and medicinal attributes. Not much work has been conducted on its medicinal applications against multidrug resistant bacteria.
Cytotoxic activities are mainly because of higher concentration of phenolics/flavonoids viz., chebulinic, chebulic, chebulagic, gallic, ellagic acid and corilagin along with related compounds. They are responsible for antimicrobial, antioxidant, antihyperglycemic, anticancer activity and protective effects on the vital body organs. So we need to search mechanism of its action for development of cheap, safe and an effective drug. Extensive investigations are required to combat diseases mainly for drug resistant infections as well as the mechanism of action. Polyphenols being valuable plant constituents help protect the body from oxidative stress and may be used in nutraceuticals and the food industry. However, studies are required to develop fractionation methods and identification of the antioxidant compounds.
This has neuroprotective activities against H2O2-induced toxicity toward PC12 cells. This is potential candidate for treatment of H2O2-induced neurodegenerative diseases. This have immunomodulatory activity which might be because of inhibition of lipid peroxidation and/or indirect stimulatory effect on both cellular and humoral immunity; and proliferation of lymphocytes as indicated by increase in the number of β and T cells which release cytokines and growth factors regulating other immune cells and secrete antibodies in the blood. T. chebula extracts have potential to protect from radiation induced damage to cellular organelles. Natural products with well-established pharmacological history are the best suited candidates as they are gifted with none or lesser side effects.
We are grateful to the Amity University Haryana authorities for the facilities and encouragement.
- C.P. Khare, Indian Medicinal Plants, 2007, 653-654.
- CSIR, 2002, 522-524.
- Varier, A dictionary of Indian raw materials and industrial products. New Delhi, 2002, 387.
- G.H. Naik, K.I. Priyadarsini, D.B. Naik, R. Gangabhagirathi, H. Mohan, Phytomedicine., 2004, 11(6), 530-538.
- A. Jokar, F. Masoomi, O. Sadeghpour, M. Nassiri-Toosi, S. Hamedi, Journal of Traditional Chinese Medicine., 2016, 36(2), 250-254.
- Jayaram, K. Kumar, Nat Prod., 2006, 2(3-4), 170-175.
- R.R. Chattopadhyay, S.K. Bhattacharyya, Pharmacog. Rev., 2007, 1(1), 151-156.
- A. Kumar, K. Lakshman, K. Jayaveera, K. Satish, S.M. Tripathi, Int. J. Aesth. Antiag. Med., 2009, 2(1), 3.
- C.P. Khare, Springer., 2004, 451-452.
- I.S. Grover, S. Bala, Indian J. Experimen. Biol., 1992, 30(4), 339-341.
- M.C. Inamdar, Indian J. Pharm., 1959, 21(12), 233-235.
- A.K. Khanna, R. Chander, N.K. Kapoor, Fitoterapia., 1993, 64(4), 351-356.
- X. Zhang, C. Chen, S. He, F. Ge, Zhong Yao Cai., 1997, 20(9), 463-464.
- E.N. Williumson, Major herbs of Ayurveda. London: Churchill Livingstone, 2002, 299.
- L.J. Juang, S.J. Sheu, T.C. Lin, J. Sep. Sci., 2004, 27(9), 718-724.
- H.S. Lee, N.H. Won, K.H. Kim, H. Lee, W. Jun, K.W. Lee, Biol. Pharm. Bull., 2005, 28(9), 1639-1644.
- A.A. Newairy, H.M. Abdou, Food Chem. Toxicol., 2009, 47, 813-818.
- M. Thakur, R.C. Rana, S. Thakur, J. Non. Timber Forest Prod., 2008, 15, 37-42.
- C. Tubtimdee, A. Shotipruk, Sep. Puri. Tech., 2011, 77(3), 339-346.
- S.N. Yoganarasimhan, Medicinal plants of India. Bangalore: Self Publication, 2000, 541.
- P. Rangsriwong, N. Rangkadilok, J. Satayavivad, M. Goto, A. Shotipruk, Sep. Puri. Tech., 2009, 66, 51-56.
- S. Muhammad, B.A. Khan, N. Akhtar, T. Mahmood, A. Rasul, I. Hussain, J. Med. Plants Res., 2012, 6(33), 4772-4775.
- D. Raju, K. Ilango, V. Chitra, K. Ashish, Pharm. Sci. Res., 2009, 1(3), 101‐107.
- B. Pfundstein, S.K. El-Desouky, W.E. Hull, R. Haubner, G. Erben, R.W. Owen, Phytochemistry., 2010, 71(10), 1132-1148.
- D. Mammen, S. Bapat, R. Sane, Int. J. Pharm. Bio. Sci., 2012, 3(1), 416-419.
- C. Chang, C.S. Land Lin, Evid. Based Complement. Alternat. Med., 2012, 7.
- S. Saha, R.J. Verma, J. Taibah University for Science., 2016, 10(6), 805-812.
- J. Bruneton, Pharmacognosy, phytochemistry, medicinal plants. Paris: Laviosier Publishing., 1995, 333.
- Q. Han, J. Song, C. Qiao, L. Wong, H. Xu, J. Sep. Sci., 2006, 29(11), 1653-1657.
- A. Kathirvel, V. Sujatha, Asian Pac. J. Trop. Biomed., 2012, S788-S795.
- R.S. Eshwarappa, A. Ramachandra, S.R. Subaramaihha, S.G. Subbaiah, R.S. Austin, B.L. Dhananjaya, Phcog. Res., 2016, 8, 78-82.
- B.E.R. Shankara, Y.L. Ramachandra, S.S. Rajan, P.S. Sujan Ganapathy, N.S. Yarla, S.A. Richard, B. Lakkappa Dhananjaya, Pharmacognosy Res., 2016, 8(3), 209-212.
- N. Kushwaha, D. Brata Mondal, V. Kumar Gupta, M.V. Jithin, J. Pharmacog. Phytochem., 2017, 6(3), 123-130.
- P. Sharma, T. Prakash, D. Kotresha, M.A. Ansari, U.R. Sahrm, K. Bimlesh, Pharm. Biol., 2011, 49(3), 262-268.
- R. Mahesh, S. Bhuvana, V.M. Begum, Cell Biochem. Funct., 2009, 27(6), 358-363.
- X. Chen, F. Sun, L. Ma, J. Wang, H. Qin, G. Du, Indian J. Pharmacol., 2011, 43(3), 320-323.
- B. Hazra, R. Sarkar, S. Biswas, N. Mandal, BMC Comp. Alter. Med., 2010, 10, 20.
- H.S. Lee, S.H. Jung, B.S. Yun, K.W. Lee, Arch Toxicol., 2007, 81(3), 211-218.
- G.H. Naik, K.I. Priyadarsini, H. Mohan, BARC Newsletter., 2012, 221-225.
- S. Sarwar, A.H. Malik, M.A. Rahman, Z. Rahman, M.S. Rana, Int. Curr. Pharm. J., 2013, 3(1), 219-222.
- C. Mathen, R. Thergaonkar, M. Teredesai, G. Soman, S. Peter, International Journal of Herbal Medicine, 2014, 2(2), 95-99.
- A. Saleem, M. Husheem, P. Harkonen, K. Pihlaja, J. Ethnopharmacol., 2002, 81(3), 327-336.
- D.B. Reddy, T.C. Reddy, G. Jyotsna, S. Sharan, N. Priya, V. Lakshmipathi, J. Ethnopharmacol., 2009, 124(3), 506-512.
- R. Ahuja, N. Agrawal, N. Mukerjee, Journal of Scientific and Innovative Research, 2013, 2(3), 549-554.
- M. Wang, L. Yang, M. Ji, P. Zhao, P. Sun, R. Bai, Y. Tian, L. Su, C. Li, Braz. Arch. Biol. Technol., 2015, 58(2).
- S.S. Kaur, K. Arora, S. Kaur, Food Chem. Toxicol., 2002, 40(4), 527-534.
- N.M. Gandhi, C.K.K. Nayar, Mol. Cell Biochem., 2005, 27(1-2), 43-48.
- S. Kaur, I.S. Grover, M. Singh, K. Kaur, Mutat. Res. Genet. Toxicol. Environ. Mutagen., 1998, 419, 169-79.
- L. Prasad, T. Husain Khan, T. Jahengir, S. Sultana, J. Trace Elem. Med. Biol., 2006, 20(4), 233-239.
- D. Johnson Benito, P. Sai Kishore, M. Verma Adarsh, A. Tamil Selvan, Research Journal of Pharmacognosy and Phytochemistry., 2010, 2(6), 459-463.
- F. Pellati, R. Bruni, D. Righi, A. Grandini, M. Tognolini, F. Pio Prencipe, F. Poli, S. Benvenuti, D. Del Rio, D. Rossi, J. Ethnopharmacol., 2013, 147(2), 277-285.
- S.A. Tasaduq, K. Singh, S. Sethi, S.C. Sharma, K.L. Bedi, J. Singh, Hum. Exp. Toxicol., 2003, 22(12), 639-645.
- S.S. Tasduq, A.K. Singh, N.K. Salti, D.K. Gupta, K. Suri, Hum. Exp. Toxicol., 2006, 25(3), 11-18.
- R. Sarkar, B. Hazra, N. Mandal, BMC Complemen. Altern. Med., 2015, 12.
- M.K. Choi, K. Hyeong-Geug, H. Jong-Min, L. Jin-Seok, L. Jong Suk, C. Sun Ho, S. Chang-Gue Mice, Evid. Based Complemen. Altern. Med., 2015, 517350, 11.
- T. Yeasmin, Q.S. Akhter, M. Tasnim, S. Jahan, Dinajpur Med. Col. J., 2016, 9(1), 78-83.
- V. Balakrishna, T. Lakshmi, Eur. J. Pharm. Med. Res., 2017, 4(4), 533-536.
- S. Suchalatha, C.S. Shyamadevi, Indian J. Exp. Biol., 2004, 42(2), 174-178.
- V.R.C. Reddy, Fitoterapia., 1990, 61, 517-525.
- C.L. Chang, C.S. Lin, G.H. Lai, Y.H. Chen, W.C. Tuan, C.M. Hsu, J. Trad. Med., 2010, 21(1), 23-30.
- N.A. Minkyun, B.A.E. Wan, S.S. Kang, B.S. Min, J.K. Yoo, O.K. Yuk, Phytother. Res., 2004, 18, 737-741.
- H.S. Lee, Y.C. Koo, H.J. Suh, K.Y. Kim, K.W. Lee, J. Ethnopharmacol., 2010, 131(3), 567-574.
- M. Na, M. Bae, S.S. Keng, B.S. Min, J.K. Yoo, Y. Kamiryo, Phytother Res., 2004, 18(9), 737-741.
- M.C. Sabu, R. Kuttan, J. Ethnopharmacol., 2002, 81(2), 155-160.
- G. Periasamy, K. Senthil, P. Arulselvan, D.K. Satish, S.P. Subramanian, J. Health Sci., 2006, 52(3), 283-291.
- N.K. Rao, S. Nammi, BMC Complemen. Altern. Med., 2006, 6, 17.
- G.P. Senthilkumar, S.P. Subramanian, J. Appl. Biomed., 2008, 6, 105-115.
- V.R. Kannan, G.S. Rajasekar, P. Rajesh, V. Balasubramanian, N. Ramesh, E.K. Solomon, Am. J. Drug Discov. Dev., 2012, 2, 135-142.
- Y. Sato, H. Oketani, K. Singyouchi, T. Ohtsubo, M. Kihara, H. Shibata, Bull. Pharm. Bull., 1997, 20(4), 401-404.
- F. Malckzadeh, H. Ehsanifar, N. Shahamat, M. Levin, R.R. Colwell, Int. J. Antimicrob. Agent., 2001, 18(1), 85-88.
- A. Ghosh, B.K. Das, A. Roy, B. Mandal, G. Chandra, J. Nat. Med., 2008, 62, 259-262.
- K.R. Aneja, R. Joshi, Jundishapur J. Microbiol., 2009, 2(3), 105-111.
- K.H. Khan, S.K. Jain, Adv. Biotech., 2009, 8(9), 10-15.
- K.H. Khan, S.K. Jain, Eur Asia J. Bio. Sci., 2009, 3, 113-121.
- P. Kannan, S.R. Ramadevi, W. Hopper, Afr. J. Microbiol. Res., 2009, 3(4), 180-184.
- P. Rani, N. Khullar, Phytother. Res., 2004, 18(8), 670-673.
- A. Agrawal, A. Gupta, N.K. Choudhary, S. Wadhwa, K. Dav, S. Goyal, Int. J. Pharm. Biol. Arch., 2010, 1(4), 485-488.
- A. Bag, S.K. Bhattacharyya, P. Bharati, N.K. Pal, R.R. Chattopadhyay, Afr. J. Plant Sci., 2009, 3(2), 25-29.
- A. Bag, S.K. Bhattacharyya, N.K. Pal, R.R. Chattopadhyay, Med. Aromatic Plant Sci. Biotech., 2011, 5(1), 70-73.
- G.H. Bonjar, Fitoterapia., 2004, 75(1), 74-76.
- B.K. Dutta, I. Rahman, T.K. Das, Mycoses., 1998, 41(11-12), 535-536.
- V.O. Barazani, P. Sathiyomoorthy, R. Shalev, D. Vardy, G.A. Golan, Phyther. Res., 2003, 17(9), 1123-1125.
- Z. Mehmood, I. Ahmad, F. Mohammad, S. Ahmad, Pharm. Biol., 1999, 37(3), 237-242.
- S.E. Mekkaway, M.R. Meselhy, I.T. Kusumoto, S. Kadota, M. Hattori, T. Namba, Chem. Pharm. Bull., 1995, 43(4), 641-648.
- M. Kurowa, K. Nagasaka, T. Hirabayashi, S. Uyama, H. Sato, T. Kagiyama, Antiviral Res., 1995, 27(1-2), 19-37.
- T.A. Yukawa, M. Kurokawa, H. Sato, Y. Yoshida, S. Kageyama, T. Hasegawa, T. Namba, M. Imakita, T. Hozumi, K. Shiraki, Antiviral Res., 1996, 32(2), 63-70.
- V. Badmaev, M. Nowakowski, Phytother. Res., 2000, 44(4), 245-249.
- M.J. Ahn, C.Y. Kim, J.S. Lee, T.G. Kim, S.H. Kim, C.K. Lee, B.B. Lee, C.G. Shin, H. Huh, J. Kim, Planta Med., 2002, 68(5), 457-459.
- A.H.N. Jeong, C.Y. Kim, J.S. Lee, T.G. Kim, S.H. Kim, C.K. Lee, Plant Med., 2002, 68, 457-459.
- K. Vermani, S. Garg, J. Ethnopharmacol., 2002, 80(1), 49-66.
- R. Gambari, L. Lampronti, Adv Phytomed., 2006, 2, 299-311.
- H. Ma, Y. Diao, D. Zhao, K. Li, T. Kang, African J. Microbiol., 2010, 4(6), 497-499.
- L.T. Lin, T.Y. Chen, C.Y. Chung, R.S. Noyce, T.B. Grindley, C. McCormick, T.C. Lin, G.H. Wang, C.C. Lin, C.D. Richardson, J. Virol., 2011, 85(9), 4386-4398.
- Y.R. Sohni, P. Kaimal, R.M. Bhatt, J. Ethnopharmacol., 1995, 45(1), 43-52.
- Y.R. Sohni, R.M. Bhatt, J. Ethnopharmacol., 1996, 54(2-3), 119-124.
- S. Dwivedi, A. Dwivedi, R. Kapadia, S. Kaul, Ethnobot. Leaflets, 2008, 12, 741-743.
- A. Bagavan, A. Rahuman, C. Kamaraj, N.K. Kaushik, D. Mohanakrishnan, D. Sahal, Parasitol. Res., 2011, 108(5), 1099-1109.
- S. Sancheti, B.H. Um, S.Y. Seo, South African J Botany., 2010, 76(2), 285-288.
- G. Nag, D. Bratati, Int. J. Pharm. Pharm. Sci., 2011, 3(3), 121-124.
- T. Moeslinger, R. Friedl, I. Volf, M. Brunner, E. Koller, P.G. Spieckermann, Can. J. Physiol. Pharmacol., 2000, 78(11), 861-866.
- V. Nair, S. Singh, Y.K. Gupta, J. Pharm. Pharmacol., 2010, 62(12), 1801-1806.
- N. Pratibha, V.S. Saxena, A. Amit, P. D'Souza, M. Bagchi, D. Bagchi, Int. J. Tissue React., 2004, 26(1-2), 43-51.
- N.N. Rege, U.M. Thatte, S.A. Dahanukar, Phytother. Res., 1999, 13, 275-291.
- T.Y. Shin, H.G. Jeong, D.K. Kim, S.H. Kim, J.K. Lee, B.S. Chae, J. Ethnopharmacol., 2001, 74, 133-140.
- V. Maruthappan, K. Sakthi, J. Adv. Pharm. Tech. Res., 2010, 1(2), 229-235.
- D.A. Israni, K.V. Patel, T.R. Gandhi, Int. J. Pharm. Sci., 2010, 1(1), 48-59.
- M.D. Tamhane, S.P. Thorate, N.N. Rege, S.A. Dahanukar, J. Postgrad. Med., 1997, 43(1), 12-13.
- A.M. Seyyed, A. Ali, K.G.N. Mohammad, M. Peyman, Malays. J. Med. Sci., 2011, 18(3), 18-26.
- A.G. Jagtap, S.G. Karkera, J. Ethnopharmacol., 1999, 68(3), 299-306.
- U. Carounanidy, R. Satyanarayanan, A. Velmurugan, Indian J. Dent. Res., 2007, 18(4), 152-156.
- K. Li, Y. Diao, H. Zhang, S. Wang, Z. Zhang, B. Yu, BMC Comp. Alter. Med., 2011, 11, 1-9.
- L. Sugun, S. Sing, P. Sivakuma, P. Sampat, G. Chandrakasa, Phytotherapy Res., 2002, 16(3), 227-231.
- S. Bhattacharya, S.R. Chaudhuri, S. Chattopadhyay, S.K. Bandyopadhyay, J. Clin. Biochem. Nutr., 2007, 41(2), 106-114.
- M.P. Singh, C.S. Sharma, Int. J. Pharm. Tech. Res., 2009, 1(4), 1267-1270.
- G.P. Choudhary, Int. J. Pharm. Bio. Sci., 2011, 2(1), 48-52.
- D. Singh, S.M. Choi, S.M. Zo, R.M. Painuli, S.W. Kwon, S.S. Han, Evid. Based Complemen. Altern. Med., 2014, 701656, 13.
- C.P. Thakur, B. Thakur, S. Singh, P.K. Sinha, S.K. Sinha, Int. J. Cardiol., 1988, 21(2), 167-175.
- A. Upadhyay, D.K. Singh, Chemosphere., 2011, 83(4), 468-474.
- C. Kamaraj, A.A. Rahuman, Res. Vet. Sci., 2011, 91(3), 400-404.
- T. Vani, M. Rajani, S. Sarkar, C.J. Shishoo, Int. J. Pharmacog., 1997, 35, 313-317.
- V.D. Aher, J. Pharm. Sci. Res., 2010, 2(9), 539-544.
- V. Aher, A.K. Wahi, Trop. J. Pharm. Res., 2011, 10(5), 567-575.
- C.L. Chang, C.S. Lin, Hung Kuang J., 2010, 61, 115-129.
- B.P. Gaire, MSc Thesis Graduate School Office Kyung Hee University, 2013.
- H.Y. Cheng, T.C. Lin, K.H. Yu, C.M. Yang, C.C. Lin, Biol. Pharm. Bull., 2003, 26, 1331-1335.
- S. Kau, R.K. Jaggi, Indian J. Exp. Biol., 2010, 48(9), 925-930.
- M. Shabbir, S.U. Islam, M.N. Bukhari, L.J. Rather, M.A. Khan, F. Mohamma, Textiles and Clothing Sustainability., 2016, 2, 1.
- R.H. Singh, B.N. Sinha, J. Res. Indian Med. Yoga Homoeo., 1978, 13, 1-8.
- J. Lee, Y.H. Nho, S.K. Yun, Y.S. Hwang, BMC Complement. Altern. Med., 2017, 17, 113.
- W. Panunto, K. Jaijoy, N. Lerdvuthisopon, N. Lertprasertsuke, N. Jiruntanat, N. Soonthornchareonnon, Int. J. Appl. Res. Nat. Prod., 2011, 3(4), 36-43.
- K. Ji-hoon, K. Yun-chang, H. Chung-Oui, Y. Sung-Yong, J. Woojin, K. Lee, Phytother. Res., 2012, 26, 39-47.
- S. Ponnusankar, S. Pandit, M. Venkatesh, A. Bandyopadhyay, P.K. Mukherjee, Phytother. Res., 2011, 25(1), 151-154.
- S. Arora, E. Brits, S. Kaur, K. Kaur, R.S. Sohi, S. Kumar, J. Environ. Pathol. Toxicol. Oncol., 2005, 24(3), 193-200.
- H.S. Rathore, M. Makwama, Biochem. Cell Arch., 2005, 5(2), 169-176.
- H.S. Rathore, B. Shazia, A. Sharma, M. Makwana, Ethnobot. Leaflets., 2006, 10, 272-279.